BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7547867)

  • 1. NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer.
    Mayo KH; Roongta V; Ilyina E; Milius R; Barker S; Quinlan C; La Rosa G; Daly TJ
    Biochemistry; 1995 Sep; 34(36):11399-409. PubMed ID: 7547867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.
    Mayo KH; Ilyina E; Roongta V; Dundas M; Joseph J; Lai CK; Maione T; Daly TJ
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):357-65. PubMed ID: 8526843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molten globule monomer to condensed dimer: role of disulfide bonds in platelet factor-4 folding and subunit association.
    Mayo KH; Barker S; Kuranda MJ; Hunt AJ; Myers JA; Maione TE
    Biochemistry; 1992 Dec; 31(48):12255-65. PubMed ID: 1457422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia.
    Mikhailov D; Young HC; Linhardt RJ; Mayo KH
    J Biol Chem; 1999 Sep; 274(36):25317-29. PubMed ID: 10464257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-affinity platelet factor 4 1H NMR derived aggregate equilibria indicate a physiologic preference for monomers over dimers and tetramers.
    Mayo KH
    Biochemistry; 1991 Jan; 30(4):925-34. PubMed ID: 1989685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of recombinant human platelet factor 4.
    Zhang X; Chen L; Bancroft DP; Lai CK; Maione TE
    Biochemistry; 1994 Jul; 33(27):8361-6. PubMed ID: 8031770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple native-like conformations trapped via self-association-induced hydrophobic collapse of the 33-residue beta-sheet domain from platelet factor 4.
    Ilyina E; Mayo KH
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):407-19. PubMed ID: 7887894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4.
    Daly TJ; LaRosa GJ; Dolich S; Maione TE; Cooper S; Broxmeyer HE
    J Biol Chem; 1995 Oct; 270(40):23282-92. PubMed ID: 7559482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptides probe folding initiation sites in platelet factor-4: stable chain reversal found within the hydrophobic sequence LIATLKNGRKISL.
    Ilyina E; Milius R; Mayo KH
    Biochemistry; 1994 Nov; 33(45):13436-44. PubMed ID: 7947752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol-induced protein folding transitions in platelet factor 4: the O-state.
    Yang Y; Mayo KH
    Biochemistry; 1993 Aug; 32(33):8661-71. PubMed ID: 8357808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human platelet factor 4 subunit association/dissociation thermodynamics and kinetics.
    Chen MJ; Mayo KH
    Biochemistry; 1991 Jul; 30(26):6402-11. PubMed ID: 2054346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model of the platelet factor 4 complex with heparin.
    Stuckey JA; St Charles R; Edwards BF
    Proteins; 1992 Oct; 14(2):277-87. PubMed ID: 1409574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution.
    St Charles R; Walz DA; Edwards BF
    J Biol Chem; 1989 Feb; 264(4):2092-9. PubMed ID: 2914894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quarternary structure amplification of protein folding differences observed in 'native' platelet factor-4.
    Barker S; Mayo KH
    FEBS Lett; 1995 Jan; 357(3):301-4. PubMed ID: 7835432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary structure of neutrophil-activating peptide-2 determined by 1H-nuclear magnetic resonance spectroscopy.
    Mayo KH; Yang Y; Daly TJ; Barry JK; La Rosa GJ
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):371-6. PubMed ID: 7998970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The solution structure of the Tyr41-->His mutant of the single-stranded DNA binding protein encoded by gene V of the filamentous bacteriophage M13.
    Folkers PJ; Nilges M; Folmer RH; Konings RN; Hilbers CW
    J Mol Biol; 1994 Feb; 236(1):229-46. PubMed ID: 8107108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity.
    Brandt S; Krauel K; Gottschalk KE; Renné T; Helm CA; Greinacher A; Block S
    Thromb Haemost; 2014 Jul; 112(1):53-64. PubMed ID: 24671506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative description of thermodynamic and kinetic properties of the platelet factor 4/heparin bonds.
    Nguyen TH; Greinacher A; Delcea M
    Nanoscale; 2015 Jun; 7(22):10130-9. PubMed ID: 25981976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three-dimensional solution structure of RANTES.
    Chung CW; Cooke RM; Proudfoot AE; Wells TN
    Biochemistry; 1995 Jul; 34(29):9307-14. PubMed ID: 7542919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.